Home / Inspections / 1233067

FDA Inspection 1233067 — Apotex Research Private Limited

Apotex Research Private Limited — FEI 3006076314

The FDA completed an inspection of Apotex Research Private Limited on March 15, 2024 in Bengaluru. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 15, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Bengaluru (India)

Facility

Other inspections at this facility

  • 1081769 (NAI Sat Feb 02 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 970670 (VAI Fri May 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 886801 (OAI Tue Jul 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 851564 (VAI Fri Jul 12 2013 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 801824 (VAI Fri Jun 22 2012 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources